DISEASE SCANNER
Global Incurable Diseases Tracker
Rhabdomyosarcoma
The most common soft tissue sarcoma in children, arising from skeletal muscle progenitors. Two main types: embryonal (including botryoid and spindle cell variants) and alveolar. Can occur anywhere in body including head/neck, genitourinary, and extremities.
20.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Biopsy
- 2Imaging (CT, MRI, PET)
- 3Tumor markers
- 4Genetic testing
- 5Endoscopy
- 6Blood tests
- 7Screening programs
Prognosis
Localized disease has 70-90% long-term survival depending on histology and site. Embryonal histology has better prognosis than alveolar. Orbit and non-parameningeal head/neck sites have best outcomes (>90%). Parameningeal and extremity sites have poorer prognosis. Metastatic disease at diagnosis has 20-30% survival. IRS/COG staging guides intensity of therapy. Late effects include growth delay, infertility, and second cancers. Long-term surveillance essential.
Prevention
- Smoking cessation
- Sun protection
- Healthy diet
- Regular exercise
- Vaccination (HPV, HBV)
- Screening programs
- Limit alcohol
- Maintain healthy weight
Research Status
Multi-agent chemotherapy (vincristine, actinomycin, cyclophosphamide). Surgery and radiation for local control. Intensified therapy for alveolar histology. Survival 70% overall; 90% for favorable sites/histology.
Affected Countries
Sources
- https://www.cancer.gov
- https://www.who.int/cancer
- https://www.cancer.org
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.